Roundup: ‘On-the-spot’ COVID-19 take a look at receives CE Mark, Thriva launches girls’s hormones take a look at and…

by akoloy



DACADOO AND DIG ANNOUNCE PARTNERSHIP IN LIFESTYLE INSURANCE

Swiss well being tech and insurtech firm, dacadoo and Amsterdam-based Digital Insurance Group (DIG) are partnering as much as develop their set of insurtech options for banking, insurance coverage and brokers.

Using a brand new quote & purchase merchandise set to enhance the underwriting course of for all times operators, the partnership goals to ascertain real-time pricing of life insurance coverage within the main continents the place each firms have already got a presence in.

Ingo Weber, CEO & co-founder of DIG stated: “Our mission is to give more people access to insurance and make sure they get the protection they need for themselves and their families. We work a lot with innovative insurers and enable them to build disruptive distribution and engagement models including ecosystems. With the solution we’re now building with dacadoo we can even increase the level of personalisation and customer experience.”


VATIC ANTIGEN TEST ACHIEVES CE MARK STATUS

British healthtech firm, Vatic has introduced that its ‘on-the-spot’ saliva antigen test for COVID-19 has acquired UK regulatory approval with CE Mark Status and has been registered with the UK Medicines and Healthcare Products Regulatory Agency (MHRA).

The saliva-only swab take a look at boasts higher comfort and luxury in comparison with nasopharyngeal or nasal swabs at the moment deployed in companies and faculties.  

The KnowNow take a look at claims to supply ends in quarter-hour, and may establish people who find themselves infectious. The know-how searches for the ‘spike’ on the virus as a measure of infectivity.  

The CE Mark registration will allow the take a look at process to be overseen by a healthcare career. Vatic is at the moment working with UK retail, transport and hospitality organisations to pilot the know-how.


AIDOC AND RADIOLOGY PARTNERS COLLABORATE ON AI ADOPTION 

Israeli AI medical imaging firm, Aidoc has partnered with US radiology observe, Radiology Partners (RP) to supply AI options to hospitals and speed up the adoption of AI in radiology.

Aidoc’s platform helps the affect of radiologist diagnostics by serving to them expedite affected person remedy by flagging acute anomalies in real-time. The firm helps radiologists enhance efficiencies that result in a discount of inpatient length-of-stay and time within the emergency division, which ends up in higher care and decrease prices.

“Health systems are coming to realise that they need an enterprise approach to AI and that it will become impossible to adopt fragmented, niche AI solutions for every subspecialty,” stated Elad Walach, CEO and co-founder of Aidoc. “Over the past four years, we’ve developed the most comprehensive acute AI suite on the market. We doubled the number of products last year and will double the portfolio again this year. A partnership between the clear leader in imaging AI and the clear leader in radiology physician services will accelerate adoption and establish an exciting new standard of care in the radiology field.”


UK HEALTHCARE TRAINING APP WITH SIMULATED WORKING ENVIRONMENTS

UK healthcare supplier, Newcross Healthcare has launched Newcross World, a brand new app-based coaching platform with simulated working environments.

Hosted on the healthcare supplier’s HealthForceGo app, the platform is at the moment utilized by 8,500 workers. With the purpose of enterprise digital modular coaching programs within the care and medical setting, the brand new app gives visible illustration of hospitals, care properties, prisons and faculties.

A brand new Virtual Shift for Complex Care at dwelling may also launch which makes use of pc gaming know-how to supply immersive, interactive experiences that prepare nurses and carers to raised assess a person’s wants.


THRIVA LAUNCHES WOMEN’S HORMONES TEST

Health monitoring platform, Thriva is launching three at-home blood checks to equip girls with actionable insights about their hormonal well being.

Created by an all-female crew of clinicians, the at-home finger-prick blood checks supply well being insights associated to PCOS, fertility insights and post-birth wellbeing. 

Consumer analysis carried out on behalf of Thriva discovered that one in three girls expertise signs associated to hormonal well being as soon as per week or extra. The analysis exhibits that sleep disturbance (65%), temper modifications (47%) and bloating (43%) are the commonest, with as much as 80% of ladies deciding to not speak to their GP about it.

Dr Sumera Shahaney, head of medical operations at Thriva, stated: “As the latest authorities announcement exhibits, there’s a damaging degree of feminine under-representation in each scientific research and well being datasets which has led, over time, to poor outcomes for ladies. We see very low consciousness of female-specific well being points and far worse, a scarcity of help for ladies dealing with hormonal well being situations. The pandemic has solely served to exacerbate this subject.”


STAY FIT LONGER PLATFORM FOR HEALTHY AGEING  

An app to assist seniors age healthily is launching a mix of gamified actions, psycho-educational steerage and social interplay options accessible on a cellular app. 

The Stay Fit Longer platform has been developed by a consortium of clinicians, teachers, consultants in neurotechnology, gaming, eHealth and aged care from Switzerland, Canada and Belgium.

This app is predicted to assist seniors age healthily and independently by enabling them to take part in a mix of bodily and cognitive workouts at dwelling.

Co-funded by the European Commission, the undertaking is a part of the European Active and Assisted Living (AAL) programme that helps the event of services primarily based on ICT options for unbiased dwelling in outdated age.


WEARABLE TECH SET TO TACKLE HEAD INJURIES IN SPORT

UK wearable tech startup, HIT Impact has developed know-how which measures and tracks head affect power in sport to assist analysis and help knowledgeable selections on the chance of mind damage.

Based on the Edinburgh Business School (EBS) Incubator inside Heriot-Watt University, the founder Euan Bowen, 28, a rugby participant, was impressed to develop the know-how after a teammate was injured.

The know-how options an affect sensor which is wearable throughout a number of sporting and exercise purposes and units. The gadget clips onto any helmet or halo headband, detecting G-Force and recording affect through a companion app.

Utilising a visitors mild system, the app information knowledge and acts as an early warning notification for the consumer concerning the extent of affect power recorded and highlights the warning required in continued train. 


QUMEA CLOSES CHF 1.8M SEED ROUND

Swiss-based AI sensor know-how startup, QUMEA has closed a CHF 1.8 million seed funding spherical to speed up its development and develop its analysis actions.

The QUMEA know-how makes use of 3D radar sensor and clever software program to simplify the monitoring of sufferers for healthcare professionals and nurses and to additionally present healthcare knowledge.

The startup goals to reply to the demand in apps that detect and scale back affected person falls and consequently relieve the burden on nursing workers. The system is already in use at quite a lot of native Swiss hospitals and nursing properties and is being at the moment examined at varied worldwide establishments.


EYEYON MEDICAL DEVICE GRANTED INNOVATIVE DEVICE STATUS

Israeli ophthalmic medical gadget startup, EyeYon Medical has introduced that its gadget for corneal edema, EndoArt was granted the Innovative Device Status by China’s Center for Medical Device Evaluation (CMDE).

Following the announcement, the gadget has turn out to be the one ophthalimic gadget on the planet to obtain each the Innovative Device Status by the Chinese NMPA and the Breakthrough Device Designation from the US Food and Drug Administration on February 2020.

The EndoArt gadget is an artificial polymer implant which allows docs to deal with power corneal edema with minimally invasive surgical procedure with out using human tissue. The gadget is designed to exchange dysfunctional endothelium in sufferers who’re ready for human donor tissue or the place human tissue has didn’t resolve the edema.


GLAMOROUSAI SECURES £440K GRANT FUNDING

GlamorousAI, a London-based AI biotech firm targeted on knowledge drug uncover, and King’s College London have launched into a collaboration to create new drug growth alternatives for Glioblastoma Multiforme mind tumours.

The firm has secured funding from Innovate UK to use its AI-first platform, Rosalind, to the initiative, in addition to usie large knowledge evaluation to assist in creating remedies.

The undertaking goals to enhance discovery of novel therapeutics targets, biomarkers and leads for the illness, which is the commonest and aggressive mind tumour in adults, with a low survival fee at 12-18 months.  

 

MobiHealthInformation is a HIMSS Media publication. 



Source link

You may also like

Leave a Reply

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

We are happy to introduce our Youtube Channel

Subscribe to get curated news from various unbias news channels
0 Shares
Share via
Copy link
Powered by Social Snap